LifePlan Financial Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$4K Hold
102
﹤0.01% 498
2020
Q2
$3K Buy
102
+80
+364% +$2.22K ﹤0.01% 517
2020
Q1
$1K Hold
22
﹤0.01% 532
2019
Q4
$1K Buy
+22
New +$524 ﹤0.01% 535

Other funds holding NEO

LifePlan Financial Group's NEO Position: Q3 2020 in Review

LifePlan Financial Group held its NeoGenomics (NEO) position steady in Q3 2020 at 102 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

LifePlan Financial Group first reported a position in NEO in Q4 2019 and has held it in 4 quarters since. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

  • LifePlan Financial Group held 102 shares of NeoGenomics worth $4K as of Q3 2020.
  • LifePlan Financial Group left its NeoGenomics share count unchanged in Q3 2020.
  • NeoGenomics made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #498 holding.
  • LifePlan Financial Group first reported a position in NeoGenomics in Q4 2019 and has held it in 4 quarters since.
  • 294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.